SEMATHERA
SemaThera is a spin-off company from AmorChem Venture Fund 1, focusing on SEMA 3A protein inhibitor in the treatment of ocular diseases, such as diabetic macular edema. This technology emerges from the laboratory of Dr Mike Sapieha, Hôpital Maisonneuve-Rosement (Montreal, Canada).
SEMATHERA
Industry:
Biotechnology Diabetes Therapeutics
Founded:
2016-01-01
Address:
Westmount, Quebec, Canada
Country:
Canada
Website Url:
http://www.semathera.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Investors List
Amorchem
Amorchem investment in Venture Round - Semathera
Senju Pharmaceutical
Senju Pharmaceutical investment in Venture Round - Semathera
Official Site Inspections
http://www.semathera.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K
- Host name: 238.168.203.35.bc.googleusercontent.com
- IP address: 35.203.168.238
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
